A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity

Title
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
Authors
Keywords
Sodium glucose cotransporter 2 inhibitor, Heart failure, Sympathetic overactivity, Cardiovascular protection
Journal
Journal of Cardiology
Volume 71, Issue 5, Pages 471-476
Publisher
Elsevier BV
Online
2018-02-04
DOI
10.1016/j.jjcc.2017.12.004

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started